New public health campaign, 'LiveLighter', has launched in South Australia, aiming to educate people about the reality of poor diet and encourage healthy food choices. The campaign includes graphic TV advertising showing the impact of toxic fat. 

New campaign targets obesity

In the first episode of this new China Biopharma English-language mini podcast, Shanghai-based senior reporter Xu Hu looks at the main directions in which obesity drug developers are moving, Chinese pharma firms’ position in the global race for muscle-preserving weight loss drugs and China's challenge in matching accessible drugs with well-guided weight loss.

Related story links:

https://insights.citeline.com/scrip/r-and-d/chinese-developers-showcase-potentially-differentiated-weight-loss-assets-at-ada-TGCGQMCVBFHS7LNTWM6YDPEC3I/;

https://insights.citeline.com/in-vivo/global-vision/chinese-firms-build-obesity-clinical-pipeline-but-face-wider-hurdles-KX5GZJDC2NGKRDO6VUU7HROF4Y/


China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 1, 2025. In this episode: EU tariff deal leaves questions for pharma; Prasad’s CBER exit could bode well for genetic medicines; Winrevair grows but Merck & Co. plans cost cuts; Novo Nordisk selects new CEO; and a look at obesity past the GLP-1s.  

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-AOJAANRHLNCPNNLNGVVKA3HEAE/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - August 4, 2025

In the latest episode of the In Vivo Podcast, Jeremy Skillington, CEO of Poolbeg Pharma, discussed the company’s ambitious pipeline and strategic direction.

Poolbeg CEO On The Biotech’s Big Bet On Small Molecules

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 15, 2025. In this episode: a look at the likely top drugs in 2030; Lilly CEO advocates US/Europe pricing rebalance; Insmed sees $5bn-plus market for Brinsupri; royalty deals go mainstream; Phase III win sets stage for Epkinly label expansion. 
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-365OXHOS2RFXHPEDQIURY6LFDI/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - August 15, 2025

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 22, 2025. In this episode: Madrigal regains MASH lead with EU Rezdiffra approval; Viking’s obesity data scare investors; China assets lead GLP-1 deals; CSL and others restructure; and Indegene exec on DTP and MFN policies.  
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-T77LV22VANAL5GNPCC2YUVLZBE/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - August 25, 2025

Clinical Professor Dr. Janey Pratt shares her passion for working with children and discusses the pressing issue of childhood obesity. As an adolescent bariatric surgeon, Dr. Pratt emphasizes that obesity is a disease. Although GLP1s — like Wegovy and Ozempic — offer some help, Dr. Pratt describes a multitude of evidence indicating surgery is a safe and more effective solution. In addition to surgery, Dr. Pratt also sheds light on Stanford’s comprehensive preoperative process for adolescent bariatric surgery, including necessary testing and evaluations to ensure patient safety as well as diet and exercise education for the whole family. 

Adolescent Obesity and Bariatric Surgery with Dr. Janey Pratt

Are Fat People Really To Blame? | Southwest Airlines, Incivility & America’s Compassion Crisis ✈️

Southwest Airlines is requiring plus-sized passengers to buy two seats so they “don’t spill over.” But here’s the real question: why not just design a few rows of larger seats? Instead, society blames fat people for being fat, ignoring the bigger issue — an industry and culture that lack compassion.

This episode of the Karel Cast digs into more than just airline seating. From body shaming to public incivility, America is in a compassion crisis. Insults fly daily, strangers fight over parking spots, and violence erupts over the smallest things. Is Trump to blame for fueling division, or is there something deeper and darker behind our collective lack of civility?

👉 Join the conversation that matters. Don’t forget to like 👍, share 🔁, comment 💬, and subscribe 🔔 to keep this dialogue alive.

The Karel Cast is supported by your donations at patreon.com/reallykarel and streams live Monday–Thursday at 10:30am PST. Available on YouTube, TikTok, Instagram, Apple Music, Spotify, iHeart Media, Spreaker, and all major platforms.

#AreFatPeopleToBlame, #SouthwestAirlines, #BodyShaming, #ObesityStigma, #AirlineSeats, #Incivility, #CompassionCrisis, #AmericanCulture, #TrumpEra, #CurrentEvents, #TrendingNow, #BreakingNews, #KarelCast, #DailyShorts, #SubscribeNow, #LikeAndShare, #StayInformed, #PoliticalTruth, #CulturalCommentary, #TruthMatters


Are Fat People Really To Blame? | Southwest Airlines, Incivility & America’s Compassion Crisis ✈️

most people over the age of 50 will deal with some form of joint osteoarthritis (OA). many of those affected by OA will attribute activity and wear and tear of life causing the worsening of OA but, the worst issues I see from OA are not from activity but from lack there of. weight will also be a contributing factor, but there is another condition I think plays a bigger part of the equation and that is Metabolic Syndrome. this condition I see with almost all my OA patients and is not being treated the right way. If you or someone you know has been affected by joint pain then this Podcast is for you. I will discuss some easy treatment options for improving overall joint pain and other interventions that may be helpful managing this condition. 

#109 True drivers of Osteoarthritis pain  - 8:25:25, 11.02 AM

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 29, 2025. In this episode: Lilly’s orforglipron strong in diabetic obesity; Ascletis confident in oral GLP-1 challenger; myostatin drugs progress for obesity; an interview with OneSource’s CEO; and an analysis of Dupixent’s pipeline-in-a-product success. 
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-KKZ7ZW3B2VGUBFTSLNCLIHU7QU/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - Sept. 1, 2025

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

The Department of Surgery at Stanford University

The best progressive talk right here, on demand. Always Progressive, Always On!

New tracks tagged #OBESITY